Results 281 to 290 of about 168,641 (363)

The role of intra‐abdominal pressure and point of care ultrasound to guide decongestive therapies in acute heart failure

open access: yesESC Heart Failure, EarlyView.
The ABDOPOCUS‐HF trial is a randomized, single‐blind, low‐intervention clinical trial (n = 168) investigating the utility of intra‐abdominal pressure (IAP) and point of care ultrasound to guide decongestive therapies during the first 72 hours after admission for acute heart failure.
C. Josa‐Laorden   +20 more
wiley   +1 more source

Circulating CD19 B cell count, myocardial injury and clinical outcomes in patients with heart failure

open access: yesESC Heart Failure, EarlyView.
Circulating CD19 B cell counts negatively correlated with myocardial injury. CD19 B cell count was an independent predictor for all‐cause mortality and HF‐related events, but not other lymphocyte subsets. Circulating CD19 B cell counts correlated to myocardial injury and could be a feasible marker for clinical outcomes in patients with HF.
Yuta Kobayashi   +11 more
wiley   +1 more source

Age‐adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study

open access: yesESC Heart Failure, EarlyView.
Abstract Background European Society of Cardiology (ESC) chronic heart failure (HF) guidelines recommend a single N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) threshold of ≥125 pg/mL for specialist referral in symptomatic patients; however, natriuretic peptide levels increase with age.
Clare J. Taylor   +5 more
wiley   +1 more source

Initial clinical experience with dapagliflozin in addition to optimized medical therapy in paediatric heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal   +5 more
wiley   +1 more source

Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect. [PDF]

open access: yesPLoS One, 2020
Ueda Y   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy